Senior insider sale
CEO at EDITAS MEDICINE, INC. — senior position signals high conviction
$45.3K
22.19K shares
What this filing means
O'NEILL GILMORE NEIL plans to sell 22.19K shares of EDITAS MEDICINE, INC. valued at approximately $45.3K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/29/2025ACC: 0001650664-25-000130
DirectorOfficer· CEO
Since Jun 2022
22.19K
Shares to sell
$45.3K
Approx. market value
11.29K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Unit Vesting
Equity Compensation
9/2/2025
11.29KTotal acquired11.29K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
9/2/2025 | Restricted Stock Unit Vesting Equity Compensation | 11.29K | — |
| Total | 11.29K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
15.19K
Market value
$26.2K
6/3/2025
Planned — Approximate Date
NasdaqPlanned
Units to sell
7K
Market value
$19.1K
9/3/2025
Total
Units
22.19K
Value
$45.3K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/3/2025 | 15.19K | $26.2K | — | Completed |
| Planned — Approximate Date | ||||
9/3/2025 | 7K | $19.1K | Nasdaq | Planned |
| Total | 22.19K | $45.3K | ||